Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2026-02-21 @ 12:39 PM
Study NCT ID:
NCT03542305
Status:
COMPLETED
Last Update Posted:
2021-02-21
First Post:
2018-05-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lorlatinib Renal Impairment Study
Sponsor:
Pfizer
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Renal Impairment | View |
Keywords: